FDA’s QMSR Recognising ISO 13485:2016: A New Era for MDR
Published Jul 25, 2024
Published 02nd October 2023
In the domain of Pharmaceutical Regulatory Affairs, regulatory agencies such as EMA and FDA are harnessing the potential of Artifical Intelligence (AI) to revolutionise assessment and oversight. While EMA and FDA are in consultation with stakeholders, we explore AI’s transformative impact and potential challenges ahead. AI enables machines to learn, think, and perform human like tasks, particularly excelling in data analysis and decision making.
Published Jul 25, 2024
Published Jul 24, 2024
Published Jul 23, 2024
Published Jul 19, 2024
Published Jul 18, 2024
Published Jul 01, 2024
Published Jul 01, 2024
Published Jun 27, 2024
Published Jun 26, 2024